FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304163249> ?p ?o ?g. }

• W4304163249 abstract "Metformin and pioglitazone monotherapy have been proven to alter gut microbiota in diabetes and obesity. The present study aimed to investigated whether the combined administration of pioglitazone and metformin achieved superior protective effects on high-fat diet (HFD)-fed obese mice and elucidated its molecular mechanism via the gut microbiota and its metabolites. C57BL/6 males were randomly divided into five groups: the control group, fed a normal control diet; the HFD group, fed an HFD; the metformin monotherapy group, fed an HFD and treated with metformin; the pioglitazone monotherapy group, fed an HFD and treated with pioglitazone; and the combination therapy group, fed an HFD and treated with metformin and pioglitazone combination therapy. The cecal contents were collected for 16S rDNA amplicon sequencing and untargeted metabolomics analysis. The results showed that the combination therapy of metformin and pioglitazone significantly improved insulin sensitivity and glucolipid metabolism in HFD-fed mice. Combination therapy markedly altered gut microbiota by increasing beneficial bacteria, such as Bifidobacterium, Christensenellaceae_R-7_group, Faecalibacterium and Roseburia, and decreasing harmful bacteria, such as Oscillibacter and Eubacterium_xylanophilum_group. Fecal metabolites were significantly changed in the combination therapy group, including a reduction in amino acid metabolism and augmentation of lipid metabolism, such as citrulline, sarcosine, D-glutamine, lipoxin A4, prostaglandin E2, stearidonic acid and lucidenic acid A. These results revealed that combined metformin and pioglitazone therapy had synergistic effects or at least have an additive effect on modifying gut microbiota and metabolites, closely associated with improved glucolipid metabolic parameters in HFD-fed mice, which provides novel evidence and promising targets for metformin and pioglitazone combination therapy in type 2 diabetes." @default.
• W4304163249 created "2022-10-11" @default.
• W4304163249 creator A5021384155 @default.
• W4304163249 creator A5043994794 @default.
• W4304163249 creator A5052441498 @default.
• W4304163249 creator A5052579493 @default.
• W4304163249 creator A5056246750 @default.
• W4304163249 creator A5059922337 @default.
• W4304163249 creator A5070373016 @default.
• W4304163249 creator A5074700770 @default.
• W4304163249 date "2022-10-11" @default.
• W4304163249 modified "2023-09-30" @default.
• W4304163249 title "Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice" @default.
• W4304163249 cites W1832132481 @default.
• W4304163249 cites W1993314172 @default.
• W4304163249 cites W2071841602 @default.
• W4304163249 cites W2073578030 @default.
• W4304163249 cites W2086865963 @default.
• W4304163249 cites W2096736123 @default.
• W4304163249 cites W2133856765 @default.
• W4304163249 cites W2160234571 @default.
• W4304163249 cites W2255443535 @default.
• W4304163249 cites W2538362615 @default.
• W4304163249 cites W2553629716 @default.
• W4304163249 cites W2607031541 @default.
• W4304163249 cites W2617940752 @default.
• W4304163249 cites W2760446596 @default.
• W4304163249 cites W2774743973 @default.
• W4304163249 cites W2791925845 @default.
• W4304163249 cites W2896002827 @default.
• W4304163249 cites W2914883768 @default.
• W4304163249 cites W2946372752 @default.
• W4304163249 cites W2953588375 @default.
• W4304163249 cites W2982686080 @default.
• W4304163249 cites W2997683965 @default.
• W4304163249 cites W2998420978 @default.
• W4304163249 cites W3009637711 @default.
• W4304163249 cites W3091468386 @default.
• W4304163249 cites W3098764920 @default.
• W4304163249 cites W3107083588 @default.
• W4304163249 cites W3111870329 @default.
• W4304163249 cites W3138062247 @default.
• W4304163249 cites W3162897796 @default.
• W4304163249 cites W3185116126 @default.
• W4304163249 cites W3187729126 @default.
• W4304163249 cites W3199456235 @default.
• W4304163249 cites W3203728677 @default.
• W4304163249 cites W3210154691 @default.
• W4304163249 cites W4200026682 @default.
• W4304163249 cites W4200586490 @default.
• W4304163249 cites W4206654541 @default.
• W4304163249 cites W4210258328 @default.
• W4304163249 cites W4213427031 @default.
• W4304163249 cites W4220762811 @default.
• W4304163249 cites W4223548207 @default.
• W4304163249 cites W4224284812 @default.
• W4304163249 cites W4224868089 @default.
• W4304163249 cites W4226343974 @default.
• W4304163249 cites W4254445254 @default.
• W4304163249 cites W4280627973 @default.
• W4304163249 cites W4281702474 @default.
• W4304163249 doi "https://doi.org/10.3389/fphar.2022.1004617" @default.
• W4304163249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36304148" @default.
• W4304163249 hasPublicationYear "2022" @default.
• W4304163249 type Work @default.
• W4304163249 citedByCount "3" @default.
• W4304163249 countsByYear W43041632492023 @default.
• W4304163249 crossrefType "journal-article" @default.
• W4304163249 hasAuthorship W4304163249A5021384155 @default.
• W4304163249 hasAuthorship W4304163249A5043994794 @default.
• W4304163249 hasAuthorship W4304163249A5052441498 @default.
• W4304163249 hasAuthorship W4304163249A5052579493 @default.
• W4304163249 hasAuthorship W4304163249A5056246750 @default.
• W4304163249 hasAuthorship W4304163249A5059922337 @default.
• W4304163249 hasAuthorship W4304163249A5070373016 @default.
• W4304163249 hasAuthorship W4304163249A5074700770 @default.
• W4304163249 hasBestOaLocation W43041632491 @default.
• W4304163249 hasConcept C100544194 @default.
• W4304163249 hasConcept C126322002 @default.
• W4304163249 hasConcept C134018914 @default.
• W4304163249 hasConcept C185592680 @default.
• W4304163249 hasConcept C2776706654 @default.
• W4304163249 hasConcept C2776999253 @default.
• W4304163249 hasConcept C2777180221 @default.
• W4304163249 hasConcept C2777477808 @default.
• W4304163249 hasConcept C2778384471 @default.
• W4304163249 hasConcept C2780206646 @default.
• W4304163249 hasConcept C2780323712 @default.
• W4304163249 hasConcept C539455810 @default.
• W4304163249 hasConcept C55493867 @default.
• W4304163249 hasConcept C555293320 @default.
• W4304163249 hasConcept C71924100 @default.
• W4304163249 hasConcept C98274493 @default.
• W4304163249 hasConceptScore W4304163249C100544194 @default.
• W4304163249 hasConceptScore W4304163249C126322002 @default.
• W4304163249 hasConceptScore W4304163249C134018914 @default.
• W4304163249 hasConceptScore W4304163249C185592680 @default.
• W4304163249 hasConceptScore W4304163249C2776706654 @default.
• W4304163249 hasConceptScore W4304163249C2776999253 @default.
• W4304163249 hasConceptScore W4304163249C2777180221 @default.

• next